Hematology Diagnostics Market Size, Share, and Analysis, By Product (Instrument, Consumables), By Test (Anemia, Hemoglobinopathy, Leukemia/Lymphoma Phenotyping, Hematology Pathophysiology, Complete Blood Count (CBC), and Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034
Hematology Diagnostics Market Size, Share, and Analysis, By Product (Instrument, Consumables), By Test (Anemia, Hemoglobinopathy, Leukemia/Lymphoma Phenotyping, Hematology Pathophysiology, Complete Blood Count (CBC), and Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034
PRODUCT OVERVIEW
Hematology Diagnostics Market, valued at USD 4.5 billion in 2023, is anticipated to grow at a steady CAGR of 5.1% from 2024 to 2034, reaching a projected market size of USD 7.8 billion by the end of the forecast period.
Hematology diagnostics involves the examination and analysis of blood and its components to diagnose a wide range of diseases and disorders. Utilizing advanced technologies such as hematology analyzers, flow cytometers, and cell counters, this field focuses on assessing blood cells, hemoglobin levels, hematocrit, and other vital parameters. These tools are crucial for diagnosing conditions like anemia, infections, clotting disorders, and blood cancers like leukemia. Recent technological advancements in hematology diagnostics, including automated high-throughput testing systems and integration with laboratory information systems, have significantly enhanced the precision, efficiency, and speed of diagnostic processes, leading to improved patient care through timely and accurate diagnosis.
MARKET HIGHLIGHTS
Hematology Diagnostics Market is expected to reach USD 7.8 billion, with a 5.1% CAGR. This growth is driven by the rising incidence of blood disorders, such as anemia, leukemia, and hemophilia, particularly among the aging population. The market is also benefiting from advancements in diagnostic technologies, such as automated and point-of-care systems, which improve both efficiency and accuracy. Additionally, increased healthcare spending and expanded access to diagnostic services in emerging economies are contributing to market expansion. Continued growth is expected as technological advancements, partnerships, and R&D efforts address the evolving needs of healthcare professionals and patients.
Hematology Diagnostics Market Segments:
Growth Drivers
Increasing Prevalence of Blood Disorders to Fuel Demand for Hematology Diagnostic Tests
Development of Advanced Hematology Analyzers and Kits to Drive Market Growth
Restraint
High Costs of Advanced Equipment Pose a Significant Challenge for Market Growth
Key Players
PRODUCT OVERVIEW
Hematology Diagnostics Market, valued at USD 4.5 billion in 2023, is anticipated to grow at a steady CAGR of 5.1% from 2024 to 2034, reaching a projected market size of USD 7.8 billion by the end of the forecast period.
Hematology diagnostics involves the examination and analysis of blood and its components to diagnose a wide range of diseases and disorders. Utilizing advanced technologies such as hematology analyzers, flow cytometers, and cell counters, this field focuses on assessing blood cells, hemoglobin levels, hematocrit, and other vital parameters. These tools are crucial for diagnosing conditions like anemia, infections, clotting disorders, and blood cancers like leukemia. Recent technological advancements in hematology diagnostics, including automated high-throughput testing systems and integration with laboratory information systems, have significantly enhanced the precision, efficiency, and speed of diagnostic processes, leading to improved patient care through timely and accurate diagnosis.
MARKET HIGHLIGHTS
Hematology Diagnostics Market is expected to reach USD 7.8 billion, with a 5.1% CAGR. This growth is driven by the rising incidence of blood disorders, such as anemia, leukemia, and hemophilia, particularly among the aging population. The market is also benefiting from advancements in diagnostic technologies, such as automated and point-of-care systems, which improve both efficiency and accuracy. Additionally, increased healthcare spending and expanded access to diagnostic services in emerging economies are contributing to market expansion. Continued growth is expected as technological advancements, partnerships, and R&D efforts address the evolving needs of healthcare professionals and patients.
Hematology Diagnostics Market Segments:
- By Product
- Instrument
- Analyzers
- Fully automated
- Semi-automated
- Flow Cytometers
- Consumables
- Reagents
- Stains
- Controls & Calibrators
- By Test
- Anemia
- Hemoglobinopathy
- Leukemia/Lymphoma Phenotyping
- Hematology Pathophysiology
- Complete Blood Count (CBC)
- Others
- By End-User
- Hospitals & Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
Growth Drivers
Increasing Prevalence of Blood Disorders to Fuel Demand for Hematology Diagnostic Tests
Development of Advanced Hematology Analyzers and Kits to Drive Market Growth
Restraint
High Costs of Advanced Equipment Pose a Significant Challenge for Market Growth
Key Players
- Sysmex Corporation
- Danaher Corporation
- Abbott Laboratories
- Siemens
- Bio-Rad Laboratories, Inc.
- Mindray Medical International Limited
- HORIBA, Ltd.
- Nihon Kohden Corporation
- Boule Diagnostics AB
- EKF Diagnostics
- Ortho Clinical Diagnostics
- Beckman Coulter, Inc.
- Shenzhen New Industries Biomedical Engineering Co., Ltd. (Snibe)
- Diatron
- Sysmex Partec GmbH
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
1.1.Regional Market Share
1.2. Business Trends
1.3.Hematology Diagnostics Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Hematology Diagnostics Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. HEMATOLOGY DIAGNOSTICS MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. RISK ANALYSIS
9. MARKET ANALYSIS
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. HEMATOLOGY DIAGNOSTICS MARKET
10.1.Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.HEMATOLOGY DIAGNOSTICS MARKET SIZE & FORECAST 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Product
11.3.1.1. Instrument
11.3.1.1.1. Analyzers
11.3.1.1.1.1.Fully automated
11.3.1.1.1.1.1.By Value (USD Million) 2024-2034F
11.3.1.1.1.1.2. Market Share (%) 2024-2034F
11.3.1.1.1.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.1.1.2. Semi-Automated
11.3.1.1.1.2.1. By Value (USD Million) 2024-2034F
11.3.1.1.1.2.2.Market Share (%) 2024-2034F
11.3.1.1.1.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.2.Consumables
11.3.1.2.1.Reagents
11.3.1.2.1.1. By Value (USD Million) 2024-2034F
11.3.1.2.1.2.Market Share (%) 2024-2034F
11.3.1.2.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.2.2. Stains
11.3.1.2.2.1.By Value (USD Million) 2024-2034F
11.3.1.2.2.2. Market Share (%) 2024-2034F
11.3.1.2.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.2.3. Controls & Calibrators
11.3.1.2.3.1.By Value (USD Million) 2024-2034F
11.3.1.2.3.2. Market Share (%) 2024-2034F
11.3.1.2.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.2. By Test
11.3.2.1.Anemia
11.3.2.1.1.By Value (USD Million) 2024-2034F
11.3.2.1.2. Market Share (%) 2024-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Hemoglobinopathy
11.3.2.2.1. By Value (USD Million) 2024-2034F
11.3.2.2.2.Market Share (%) 2024-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.3. Leukemia/Lymphoma Phenotyping
11.3.2.3.1. By Value (USD Million) 2024-2034F
11.3.2.3.2.Market Share (%) 2024-2034F
11.3.2.3.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.4. Hematology Pathophysiology
11.3.2.4.1. By Value (USD Million) 2024-2034F
11.3.2.4.2.Market Share (%) 2024-2034F
11.3.2.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.5. Complete Blood Count (CBC)
11.3.2.5.1. By Value (USD Million) 2024-2034F
11.3.2.5.2.Market Share (%) 2024-2034F
11.3.2.5.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.6. Others
11.3.2.6.1. By Value (USD Million) 2024-2034F
11.3.2.6.2.Market Share (%) 2024-2034F
11.3.2.6.3.Y-o-Y Growth (%) 2024-2034F
11.3.3. By End-User
11.3.3.1.Hospitals & Clinics
11.3.3.1.1.By Value (USD Million) 2024-2034F
11.3.3.1.2. Market Share (%) 2024-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Diagnostics Laboratories
11.3.3.2.1. By Value (USD Million) 2024-2034F
11.3.3.2.2.Market Share (%) 2024-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.3. Academic & Research Institutes
11.3.3.3.1. By Value (USD Million) 2024-2034F
11.3.3.3.2.Market Share (%) 2024-2034F
11.3.3.3.3.Y-o-Y Growth (%) 2024-2034F
12. NORTH AMERICA HEMATOLOGY DIAGNOSTICS MARKET SIZE & FORECAST 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product
12.3.2.By Test
12.3.3.By End-User
12.4. Country
12.4.1.United States
12.4.2.Canada
13. EUROPE HEMATOLOGY DIAGNOSTICS MARKET SIZE & FORECAST 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product
13.3.2.By Test
13.3.3.By End-User
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. ASIA-PACIFIC HEMATOLOGY DIAGNOSTICS MARKET SIZE & FORECAST 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product
14.3.2.By Test
14.3.3.By End-User
14.4. Country
14.4.1. India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. MIDDLE EAST AND AFRICA HEMATOLOGY DIAGNOSTICS MARKET SIZE & FORECAST 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product
15.3.2.By Test
15.3.3.By End-User
15.4. Country
15.4.1. Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4. South Africa
15.4.5.Rest of Middle East and Africa
16. LATIN AMERICA HEMATOLOGY DIAGNOSTICS MARKET SIZE & FORECAST 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product
16.3.2.By Test
16.3.3.By End-User
16.4. Country
16.4.1. Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1. Company market share, 2023
17.2.Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1. Sysmex Corporation
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2.Danaher Corporation
18.3.Abbott Laboratories
18.4.Siemens
18.5.Bio-Rad Laboratories, Inc.
18.6.Mindray Medical International Limited
18.7.HORIBA, Ltd.
18.8.Nihon Kohden Corporation
18.9.Boule Diagnostics AB
18.10.EKF Diagnostics
18.11. Ortho Clinical Diagnostics
18.12.Beckman Coulter, Inc.
18.13.Shenzhen New Industries Biomedical Engineering Co., Ltd. (Snibe)
18.14.Diatron
18.15.Sysmex Partec GmbH
18.16.Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
1.1.Regional Market Share
1.2. Business Trends
1.3.Hematology Diagnostics Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Hematology Diagnostics Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. HEMATOLOGY DIAGNOSTICS MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. RISK ANALYSIS
9. MARKET ANALYSIS
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. HEMATOLOGY DIAGNOSTICS MARKET
10.1.Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.HEMATOLOGY DIAGNOSTICS MARKET SIZE & FORECAST 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Product
11.3.1.1. Instrument
11.3.1.1.1. Analyzers
11.3.1.1.1.1.Fully automated
11.3.1.1.1.1.1.By Value (USD Million) 2024-2034F
11.3.1.1.1.1.2. Market Share (%) 2024-2034F
11.3.1.1.1.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.1.1.2. Semi-Automated
11.3.1.1.1.2.1. By Value (USD Million) 2024-2034F
11.3.1.1.1.2.2.Market Share (%) 2024-2034F
11.3.1.1.1.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.2.Consumables
11.3.1.2.1.Reagents
11.3.1.2.1.1. By Value (USD Million) 2024-2034F
11.3.1.2.1.2.Market Share (%) 2024-2034F
11.3.1.2.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.2.2. Stains
11.3.1.2.2.1.By Value (USD Million) 2024-2034F
11.3.1.2.2.2. Market Share (%) 2024-2034F
11.3.1.2.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.2.3. Controls & Calibrators
11.3.1.2.3.1.By Value (USD Million) 2024-2034F
11.3.1.2.3.2. Market Share (%) 2024-2034F
11.3.1.2.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.2. By Test
11.3.2.1.Anemia
11.3.2.1.1.By Value (USD Million) 2024-2034F
11.3.2.1.2. Market Share (%) 2024-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Hemoglobinopathy
11.3.2.2.1. By Value (USD Million) 2024-2034F
11.3.2.2.2.Market Share (%) 2024-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.3. Leukemia/Lymphoma Phenotyping
11.3.2.3.1. By Value (USD Million) 2024-2034F
11.3.2.3.2.Market Share (%) 2024-2034F
11.3.2.3.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.4. Hematology Pathophysiology
11.3.2.4.1. By Value (USD Million) 2024-2034F
11.3.2.4.2.Market Share (%) 2024-2034F
11.3.2.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.5. Complete Blood Count (CBC)
11.3.2.5.1. By Value (USD Million) 2024-2034F
11.3.2.5.2.Market Share (%) 2024-2034F
11.3.2.5.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.6. Others
11.3.2.6.1. By Value (USD Million) 2024-2034F
11.3.2.6.2.Market Share (%) 2024-2034F
11.3.2.6.3.Y-o-Y Growth (%) 2024-2034F
11.3.3. By End-User
11.3.3.1.Hospitals & Clinics
11.3.3.1.1.By Value (USD Million) 2024-2034F
11.3.3.1.2. Market Share (%) 2024-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Diagnostics Laboratories
11.3.3.2.1. By Value (USD Million) 2024-2034F
11.3.3.2.2.Market Share (%) 2024-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.3. Academic & Research Institutes
11.3.3.3.1. By Value (USD Million) 2024-2034F
11.3.3.3.2.Market Share (%) 2024-2034F
11.3.3.3.3.Y-o-Y Growth (%) 2024-2034F
12. NORTH AMERICA HEMATOLOGY DIAGNOSTICS MARKET SIZE & FORECAST 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product
12.3.2.By Test
12.3.3.By End-User
12.4. Country
12.4.1.United States
12.4.2.Canada
13. EUROPE HEMATOLOGY DIAGNOSTICS MARKET SIZE & FORECAST 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product
13.3.2.By Test
13.3.3.By End-User
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. ASIA-PACIFIC HEMATOLOGY DIAGNOSTICS MARKET SIZE & FORECAST 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product
14.3.2.By Test
14.3.3.By End-User
14.4. Country
14.4.1. India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. MIDDLE EAST AND AFRICA HEMATOLOGY DIAGNOSTICS MARKET SIZE & FORECAST 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product
15.3.2.By Test
15.3.3.By End-User
15.4. Country
15.4.1. Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4. South Africa
15.4.5.Rest of Middle East and Africa
16. LATIN AMERICA HEMATOLOGY DIAGNOSTICS MARKET SIZE & FORECAST 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product
16.3.2.By Test
16.3.3.By End-User
16.4. Country
16.4.1. Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1. Company market share, 2023
17.2.Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1. Sysmex Corporation
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2.Danaher Corporation
18.3.Abbott Laboratories
18.4.Siemens
18.5.Bio-Rad Laboratories, Inc.
18.6.Mindray Medical International Limited
18.7.HORIBA, Ltd.
18.8.Nihon Kohden Corporation
18.9.Boule Diagnostics AB
18.10.EKF Diagnostics
18.11. Ortho Clinical Diagnostics
18.12.Beckman Coulter, Inc.
18.13.Shenzhen New Industries Biomedical Engineering Co., Ltd. (Snibe)
18.14.Diatron
18.15.Sysmex Partec GmbH
18.16.Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
